Oramed Pharmaceuticals
ORMP
#9035
Rank
โ‚น7.79 B
Marketcap
โ‚น190.90
Share price
-3.86%
Change (1 day)
-6.19%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): โ‚น4.68 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of โ‚น0.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น30.08 M-95.05%
2023 โ‚น0.60 B-119.45%
2022 -โ‚น3.13 Billion39.17%
2021 -โ‚น2.25 Billion73.93%
2020 -โ‚น1.29 Billion18.53%
2019 -โ‚น1.09 Billion-16.62%
2018 -โ‚น1.31 Billion38.32%
2017 -โ‚น0.95 Billion12.51%
2016 -โ‚น0.84 Billion25.01%
2015 -โ‚น0.68 Billion18.18%
2014 -โ‚น0.57 Billion39.72%
2013 -โ‚น0.41 Billion46.4%
2012 -โ‚น0.28 Billion128.32%
2011 -โ‚น0.13 Billion-51.47%
2010 -โ‚น0.26 Billion35.21%
2009 -โ‚น0.19 Billion
2007 -โ‚น0.3 Billion607.04%
2006 -โ‚น41.19 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น43 Billion-143,030.59%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.614 T 5,365,367.42%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
โ‚น748.31 B 2,487,273.94%๐Ÿ‡ซ๐Ÿ‡ท France
-โ‚น0.83 Billion-2,850.42%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-โ‚น17.08 Billion-56,871.39%๐Ÿ‡บ๐Ÿ‡ธ USA